AVENUE THERAPEUTICS, INC. (ATXI)

OTC Pharmaceutical Pharmaceutical Preparations SIC: 2834
D
Pipeline Grade

Financial Position (from SEC Filings)

$6.7M
Cash & Equivalents
$0.4M
Quarterly Burn Rate
46 mo
Est. Cash Runway
$1M
Market Cap

Estimated from most recent SEC quarterly filing. View SEC filings

Drug Pipeline (0 Assets)

No drugs indexed yet. Pipeline data is populated from ClinicalTrials.gov and openFDA.

Upcoming Catalysts

No upcoming catalysts detected for this company.

Active Clinical Trials (1)

NCT #TitlePhaseStatusEnrollment
NCT03774836 Tramadol Versus Placebo and Morphine in the Management of Post-Operative Pain Abdominoplasty PHASE3 Active Not Recruiting 360

Source: ClinicalTrials.gov. Trial status last updated by sponsor — may not reflect current state.

More Analysis

AI Stock Score

SEC EDGAR fundamental analysis with Claude AI & ChatGPT ratings for ATXI.

SEC EDGAR Filings

All SEC filings for AVENUE THERAPEUTICS, INC. on EDGAR.

Full Calendar

View all upcoming FDA catalysts across all biotech companies.